Wegovy Price Checker: What Private Treatment Costs in the UK

The biggest myth: a low headline price means a lower total cost

The most common misconception when people use a Wegovy price checker is that the monthly figure shown is the complete cost. It rarely is. A headline price might cover the pen only, no clinical consultation, no prescription fee, no delivery, no aftercare. When you add those separately, the gap between a seemingly cheap listing and a genuinely all-in service often closes entirely. Sometimes it reverses.

Wegovy (semaglutide) is a prescription-only medicine regulated by the MHRA. Every legitimate supply in the UK requires a prescriber to assess your health, issue a prescription, and make that prescription available to a GPhC-registered pharmacy. Understanding how Wegovy works as a treatment helps clarify why clinical oversight isn't a formality you can skip for a saving, it's the thing that makes the medicine safe for you specifically. Providers who charge separately for consultation, prescription, delivery and follow-up are not offering you a better deal; they're showing you a number that invites a favourable comparison before you see the full picture.

The MHRA maintains the GPhC register so that patients can verify any online pharmacy dispensing prescription medicines. You can check any UK pharmacy at the GPhC register before handing over personal or financial details. That step takes about forty seconds. It's worth taking.

What the range of Wegovy prices in the UK reflects

Private Wegovy pricing in the UK is not arbitrary. It moves with dose. Treatment starts at 0.25 mg and is titrated upward by the prescriber, typically in monthly steps, toward 2.4 mg or the newer 7.2 mg maintenance dose approved by the MHRA in April 2026. Lower doses cost less per pen; higher doses cost more. That means a price you see quoted may be for the starter dose rather than the maintenance dose you'll eventually reach, and the two figures can differ substantially. If you want to understand how the starter dose is priced specifically, our guide to Wegovy 1 mg pricing walks through what that early stage of treatment typically costs.

As widely reported in August 2025, list price changes from manufacturers have fed through to private market rates. Typical private prices since then range roughly £149–£375 per month depending on dose and provider, and our overview of Wegovy pricing sets out how those figures break down across the full titration schedule. These are background figures to orient your expectations; actual treatment pricing at any regulated service is confirmed at consultation, because the appropriate dose for you is a clinical decision, not a menu choice. A fuller breakdown of Wegovy cost factors covers how dose changes affect what you pay over the course of treatment.

One practical timing note: orders placed before midday Monday to Friday at a service like ours reach you the next working day via DPD. If you order just before a bank holiday, factor in that the clock stops over the break, worth checking before payday spending goes to a next-day delivery that won't actually arrive until Tuesday.

What our single transparent price covers, and why we are not trying to be the cheapest

At nume, one price covers everything: the clinical consultation, the prescription, the medicine, delivery and ongoing aftercare. There are no bolt-ons. There is no subscription auto-renewing without your knowledge. Every repeat order is clinically re-reviewed by a GPhC-registered Independent Prescriber before anything is dispensed. You can see current treatment pricing on our treatment page, and you'll find context on the FAQs if you have questions before starting.

We're not entering a race to the lowest price. The clinical infrastructure that makes Wegovy safe (identity verification, live weight checks on video, GP notification, Summary Care Record checks, evidence review for dose increases) adds cost. We think that cost is the point. Our approach as a service reflects the view that a prescription medicine needs prescription-level care around it, and that care is not free. If you want to compare what is included at different price points, our Wegovy price check guide explains what to look for when assessing whether a quoted figure represents genuine value. If a price checker is showing you figures significantly below the typical private market range, ask what the clinical pathway looks like before you commit.

Why 'cheapest' is the wrong question to bring to a Wegovy price comparison

Wegovy is a prescription-only medicine. Its risks (including the gastrointestinal side effects that affect most patients early in treatment, and the less common but serious signals flagged in MHRA safety communications) are managed through proper clinical monitoring, not by a written disclaimer in a checkout flow. The NICE recommendation for semaglutide (Wegovy) under NICE TA875 situates it within structured clinical management for a reason. That context doesn't disappear in the private market.

The MHRA has issued repeated warnings about counterfeit and illegally traded weight-loss pens sold online, including the first known UK site manufacturing fake tirzepatide pens raided in late 2025. Prices far below the market range are one of the clearest red flags. Sellers offering these medicines without a prescription, on social media, or with discount codes attached are not competing on service, they're operating outside the law. You can report a suspect seller via the MHRA Yellow Card scheme. The right question when comparing Wegovy providers is not who is cheapest, but who can demonstrate a genuine, verifiable clinical pathway. More on what very low Wegovy prices usually signal explains the red flags in detail. If you're ready to see whether treatment is right for you, check your eligibility with our prescribers, the consultation is free.